Ultragenyx Pharmaceutical Inc header image

Ultragenyx Pharmaceutical Inc

RARE

Equity

ISIN null / Valor 22860122

NASDAQ (2026-02-18)

USD 20.45+1.34%

Ultragenyx Pharmaceutical Inc
UMushroom community rating:

3.20 10 votes No rating yet

NegativeNeutralPositive

About company

Ultragenyx Pharmaceutical Inc is a biopharmaceutical company that focuses on developing and commercializing innovative treatments for rare and ultra-rare genetic diseases. The company's portfolio includes products such as DOJOLVI® for long-chain fatty acid oxidation disorders and CRYSVITA® for X-linked hypophosphatemia and tumor-induced osteomalacia. Ultragenyx is dedicated to providing patients with life-changing therapies that address unmet medical needs in the rare disease community.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-53.1%1Y

-58.0%3Y

-85.7%5Y

Performance

78.8%1Y

58.6%3Y

56.8%5Y

Volatility

1973 M

Market cap (USD)

2,113,176

Daily traded volume (Shares)

43.045 / 41.53

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

3.20

10 votes

Performance:

3.50

Innovation:

3.60

Society:

3.40

Nature:

3.10

oliver baigel

United Kingdom, 09 Nov 2025

a very low performing stock with a high level of risk

Yam Yi Pan

United Kingdom, 08 Nov 2025

1

Misha Batvinov

United Kingdom, 07 Nov 2025

ok

EQUITIES OF THE SAME SECTOR

Hims & Hers Health Inc

Hims & Hers Health Inc Valor: 59397181

Annual Return

-50%0%+50%

Risk level

110

-2.64%USD 15.84

H. Lundbeck A/S

H. Lundbeck A/S Valor: 119252584

Annual Return

-50%0%+50%

Risk level

110

0.83%DKK 36.45

Envista Holdings Corporation

Envista Holdings Corporation Valor: 49153522

Annual Return

-50%0%+50%

Risk level

110

1.53%USD 28.50

Astrana Health Inc

Astrana Health Inc Valor: 28041888

Annual Return

-50%0%+50%

Risk level

110

1.20%USD 19.45

Dr Reddy'S Laboratories Ltd

Dr Reddy'S Laboratories Ltd Valor: 1221723

Annual Return

-50%0%+50%

Risk level

110

0.14%USD 14.42

Coty Inc

Coty Inc Valor: 1645885

Annual Return

-50%0%+50%

Risk level

110

1.95%USD 2.61

Penumbra Inc

Penumbra Inc Valor: 29290920

Annual Return

-50%0%+50%

Risk level

110

0.09%USD 341.32

Gyre Therapeutics Inc

Gyre Therapeutics Inc Valor: 130270397

Annual Return

-50%0%+50%

Risk level

110

0.00%USD 8.21

Ambu A/S

Ambu A/S Valor: 39639588

Annual Return

-50%0%+50%

Risk level

110

-0.67%DKK 81.05

Embla Medical hf

Embla Medical hf Valor: 1060135

Annual Return

-50%0%+50%

Risk level

110

-0.66%DKK 30.10

SIX

FactSet

Clearbit

Logos provided by Clearbit